Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of January 18, 2026

By / January 22, 2026

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

TAVALISSE (fostamatinib disodium)

Rigel pharms Patent: 9,266,912 Expiration: Jan 19, 2026

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

Patent Term Extension Calculator: Step-by-Step Expert Guide
The Patent Cliff and Beyond: A Definitive Guide to…
The Post-Exclusivity Event Horizon: Strategic…
Build a Fortress, Not a Wall: Why the Patent Cliff…
Profit From Weak Drug Patents: Identifying Weak…
The Patent Playbook for Pharma: Protect Your Drug.…
The BTD Paradox: How Accelerated Approval Reshapes…
Orange Book vs. Purple Book: Strategic Differences…
The Dragon Awakes: Charting the Unstoppable Growth…
Drug Formulation Stability for Business Development:…
Effective Drug Patent Prosecution Strategies:…
Fix the Formula to Win the Generic Race: Overcoming…
The 1,825-day head start: How to stop a generic…
The Innovator's Compass: Navigating the Patent…
What are the top Biopharmaceutical Business…
Tracking Generic Drug Launches: A Strategic Guide…
Beyond the Drug Patent Cliff: How Procurement Can…
Maximizing Pharmaceutical Patent Longevity: A…
Build a Live Drug Patent LOE Dashboard Your…
The Asset Rescue Playbook: Turning Off-Patent Data…
The Asymmetric Advantage: Advanced Pharmaceutical…
Decoding the FDA Orange Book's Therapeutic…
The Uncoupling of Device and Drug: A Strategic…
The 2026 Pharmaceutical Innovation Frontier: A…

The Asymmetric Advantage: Advanced Pharmaceutical Competitor Analysis in the Age of Patent Cliffs and Policy Shocks

When One Lawsuit Isn’t Enough: Serial Patent Litigation and Its Impact on Generic Timelines

Related Posts

Drug Patent Expirations for the Week of January 4, 2026

Patent Expiration / By

Drug Patent Expirations for the Week of February 1, 2026

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

Slash drug discovery timelines with GPT-Rosalind
Sell Before the Drug Patent Expiration Cliff: A guide for Commercial & Market Access Vendors using anticipated Loss of Exclusivity dates to offer contracting strategy support before generic entry
Authorized Generics: The Innovator’s Playbook for Diluting First-Filer Profits
Read the Clock Right: Mapping Regulatory Exclusivities for True Generic Drug Entry Timing
Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked

Popular Posts

CHEMOCENTRYX, INC. v. ZYDUS PHARMACEUTICALS (USA) INC.
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
Patent Expiration Dates: The Calendar Every Pharmaceutical Investor Watches
Maximizing Pharmaceutical Patent Longevity: A Mechanistic and Strategic Guide to IP Term Extension and Lifecycle Fortification
Brazilian Pharmaceuticals 2026: The Innovation & Patent Cliff Frontier
China’s Irreplaceable Role in the Global Generic Drug API Supply Chain (2026 Report)
The Top 10 Longest-Running Drug Patents
Drug Patent Expiration: The Complete Strategic Guide to Loss of Exclusivity, Lifecycle Management, and the $400 Billion Cliff
The Ultimate Guide to CDMO Pricing
What are the top Biopharmaceutical Business Intelligence Services?

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested

Last Updated on January 22, 2026 by